Biotechnology company Eyenovia launches HYPE treasury reserve strategy, planning to invest $50 million
BlockBeats News, June 18, according to market reports, clinical-stage ophthalmic biopharmaceutical company Eyenovia announced an investment of $50 million to launch the Hyperliquid (HYPE) treasury reserve strategy.